Publicação
The H5N1 infl uenza: what you need to know and what to expect
| Resumo: | The infl uenza A (H5N1) virus, after the fi rst documented human infection in 1997, has been responsible for a growing number of cases in humans, especially since 2003. The increasing number of cases and a mortality rate of 51%, has lead to fears that should the virus acquire the ability to transmit from human to human, a serious world pandemic of H5N1 infl uenza will occur.In order to combat such an eventuality efforts have targeted research and disease control in Asian countries where H5N1 infl uenza cases have been reported. It is possible that these efforts are insuffi cient, and research for a H5N1 specifi c vaccine is being pursued as well as other control measures. One of these measures could be the use of antiviral therapy, such as oseltamivir, aiming to reduce the severity and transmissibility of the disease. |
|---|---|
| Autores principais: | Bento, Ângela |
| Outros Autores: | Tribolet de Abreu, Tiago |
| Assunto: | Influenza vírus influenza A aviário Influenza influenza A virus avian |
| Ano: | 2006 |
| País: | Portugal |
| Tipo de documento: | artigo |
| Instituição associada: | Sociedade Portuguesa de Medicina Interna |
| Idioma: | português |
| Origem: | Revista Portuguesa de Medicina Interna |
| Resumo: | The infl uenza A (H5N1) virus, after the fi rst documented human infection in 1997, has been responsible for a growing number of cases in humans, especially since 2003. The increasing number of cases and a mortality rate of 51%, has lead to fears that should the virus acquire the ability to transmit from human to human, a serious world pandemic of H5N1 infl uenza will occur.In order to combat such an eventuality efforts have targeted research and disease control in Asian countries where H5N1 infl uenza cases have been reported. It is possible that these efforts are insuffi cient, and research for a H5N1 specifi c vaccine is being pursued as well as other control measures. One of these measures could be the use of antiviral therapy, such as oseltamivir, aiming to reduce the severity and transmissibility of the disease. |
|---|